Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Dec 28, 2024; 30(48): 5130-5151
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5130
Figure 2
Figure 2 Relationship between systemic immune-inflammation index/albumin and both overall survival and recurrence-free survival. A: Examination of the dose-response relationship between systemic immune-inflammation index/albumin (SII/ALB) and 5-year overall survival (OS) by the restricted cubic splines model; B: Cut-off value of SII/ALB in patients with hepatocellular carcinoma; C: Kaplan-Meier curves depicting the association between SII/ALB and OS; D: Kaplan-Meier curves depicting the association between SII/ALB and recurrence-free survival. SII/ALB: Systemic immune-inflammation index/albumin.